FABRIS, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 20.007
EU - Europa 9.933
AS - Asia 7.962
SA - Sud America 949
Continente sconosciuto - Info sul continente non disponibili 731
AF - Africa 311
OC - Oceania 26
Totale 39.919
Nazione #
US - Stati Uniti d'America 19.671
SG - Singapore 2.938
PL - Polonia 2.847
CN - Cina 1.781
IT - Italia 1.663
SE - Svezia 1.316
UA - Ucraina 876
HK - Hong Kong 766
BR - Brasile 749
VN - Vietnam 745
DE - Germania 607
FI - Finlandia 497
KR - Corea 442
FR - Francia 413
GB - Regno Unito 375
TR - Turchia 349
RU - Federazione Russa 318
BD - Bangladesh 275
NL - Olanda 238
BG - Bulgaria 190
IE - Irlanda 189
IN - India 188
CA - Canada 159
MA - Marocco 121
MX - Messico 96
CH - Svizzera 79
BE - Belgio 69
JP - Giappone 68
AR - Argentina 63
ES - Italia 57
ZA - Sudafrica 56
CZ - Repubblica Ceca 49
IQ - Iraq 47
AT - Austria 40
SA - Arabia Saudita 38
EG - Egitto 33
EC - Ecuador 30
PH - Filippine 30
ID - Indonesia 29
MY - Malesia 27
PK - Pakistan 27
VE - Venezuela 23
SN - Senegal 22
DZ - Algeria 21
AU - Australia 20
CL - Cile 19
CO - Colombia 19
EU - Europa 18
IL - Israele 17
JO - Giordania 17
IR - Iran 16
AZ - Azerbaigian 15
PY - Paraguay 15
TH - Thailandia 15
CR - Costa Rica 14
RO - Romania 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
KZ - Kazakistan 13
BO - Bolivia 12
NP - Nepal 11
TN - Tunisia 11
TW - Taiwan 11
ET - Etiopia 10
GR - Grecia 10
JM - Giamaica 10
LT - Lituania 10
NI - Nicaragua 10
RS - Serbia 10
GT - Guatemala 9
PE - Perù 9
PT - Portogallo 9
UY - Uruguay 9
AL - Albania 8
KE - Kenya 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
CY - Cipro 7
HU - Ungheria 7
LB - Libano 7
LK - Sri Lanka 7
LV - Lettonia 6
MD - Moldavia 6
OM - Oman 6
PA - Panama 6
CD - Congo 5
HN - Honduras 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
QA - Qatar 5
DO - Repubblica Dominicana 4
KW - Kuwait 4
MM - Myanmar 4
NG - Nigeria 4
PS - Palestinian Territory 4
SI - Slovenia 4
SV - El Salvador 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 39.145
Città #
Warsaw 2.659
Ashburn 2.047
Singapore 1.733
Woodbridge 1.715
Fairfield 1.533
Houston 1.366
Ann Arbor 1.256
Chandler 1.223
San Jose 958
Wilmington 767
Jacksonville 766
Hong Kong 745
Seattle 631
Cambridge 501
Beijing 453
Seoul 435
Council Bluffs 368
Hefei 362
Trieste 326
Princeton 323
Boardman 321
Chicago 300
Columbus 297
Los Angeles 290
Izmir 256
Ho Chi Minh City 222
Dallas 195
Munich 189
Sofia 187
Dublin 181
Lauterbourg 181
Hanoi 176
Helsinki 169
Milan 169
The Dalles 165
Santa Clara 163
Zgierz 163
Moscow 154
New York 141
Frankfurt am Main 123
Dearborn 120
Düsseldorf 114
Casablanca 109
Buffalo 107
San Diego 87
Phoenix 85
London 83
São Paulo 76
Bern 69
Rome 66
Brussels 65
Shanghai 56
Atlanta 55
Memphis 55
Orem 55
Des Moines 53
Tokyo 52
Washington 51
Falls Church 48
North Bergen 48
Brooklyn 46
Dong Ket 46
Montreal 45
Salt Lake City 44
Jinan 41
Turku 41
Amsterdam 39
Boston 37
Nanjing 35
Da Nang 34
Haiphong 33
Kocaeli 33
Norwalk 33
Johannesburg 32
Redmond 31
Redondo Beach 31
San Francisco 30
Chennai 29
Denver 29
Nuremberg 29
Redwood City 28
Tampa 28
Toronto 28
Vienna 28
Guangzhou 27
Miano 27
Verona 27
Elk Grove Village 25
Bremen 24
Lappeenranta 24
Prague 24
Venezia 24
Mestre 23
Stockholm 23
Dakar 22
Mexico City 22
Mumbai 22
Rio de Janeiro 21
Manchester 20
Ankara 19
Totale 26.867
Nome #
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 635
A case report of hyponatremia after surgery for Conn's adenoma 545
Aldosterone effects on glomerular structure and function 490
A new ultrasonographic instrument for measuring vessel wall shear stress. 488
A case report of malignant hypertension in a young woman 487
Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules 485
Surgical and pathological changes after radiofrequency ablation of thyroid nodules 447
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 431
TRAIL Modulates the Immune System and Protects against the Development of Diabetes 430
Baroreceptor-heart rate reflex sensitivity enhancement after urinary bladder distention in essential hypertensives 428
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease 427
Cross-sex hormone therapy for gender dysphoria 423
Association between thyroid hormones and TRAIL 423
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 422
A prospective study on the efficacy of patient simulation in heart and lung auscultation 419
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 378
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 353
12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules 342
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 330
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 330
Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey 320
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 316
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 305
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 302
Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? 300
Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism 293
Estimation of Aortic Stiffness with Bramwell-Hill Equation: A Comparative Analysis with Carotid-Femoral Pulse Wave Velocity 291
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7) 281
Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center 280
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 279
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 277
Radiofrequency ablation for benign thyroid nodules 277
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 275
Ambulatory Arterial Stiffness Indexes in Acromegaly. 274
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. 273
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. 272
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 269
A pheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule. 266
Influence of carotid atherosclerotic plaques on pulse wave assessment with arterial tonometry 263
Systemic and regional haemodynamic effects of aortofemoral angiography 262
Exploratory case-control study on ACE2 expression in children with short stature 258
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 256
ACE2 deficiency shifts energy metabolism towards glucose utilization 256
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 254
Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause 254
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 254
Full-Thickness Skin Burn Caused by Radiofrequency Ablation of a Benign Thyroid Nodule 249
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System 247
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 247
Antihypertensive activity of arylidenaminoguanidine derivatives. 246
Acute effects of intravenous infusions of alcohol on baroreceptor sensitivity in essential hypertension. 243
Apoptosis-inducing molecules and uses therefor 241
Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome 241
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 240
Supplementation of Omega-3 Polyunsaturated Fatty Acids Prevents Increase in Arterial Stiffness After Experimental Menopause 236
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 235
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 234
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 232
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]. 229
Ace inhibition in renal disease: risks and benefits. 229
Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients. 228
TRAIL shows potential cardioprotective activity. 226
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 224
The cardiac renin-angiotensin system in heart failure 223
Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules 219
TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet-fed mouse 218
High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage 217
A case of cerebral salt wasting syndrome in a patient with central diabetes insipidus and status epilepticus 216
Reduction of blood pressure in obese hyperinsulinaemic hypertensive patients during somatostatin infusion 216
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists 215
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 214
An ultrasonographic method to measure the sensitivity of the baroreflex in clinical practice: application to pharmacological studies. 212
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 212
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 211
Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism 211
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 209
Il Transessualismo: identificazione di un percorso diagnostico e terapeutico. Kurtis Editrice, Milano 1999. 209
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. 207
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 206
TRAIL treatment prevents renal morphological changes and TGF-β-induced mesenchymal transition associated with diabetic nephropathy 206
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 205
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome. 205
Baroreflex function after therapy withdrawal in patients with essential hypertension 204
[Adenylate cyclase activity--after stimulation of beta-receptors with isoproterenol--in relation to the presence or absence of monocytes in a population of mononucleated cells]. 203
High salt diet ameliorates effects of angiotensin converting enzyme inhibition in spontaneously hypertensive streptozotocin diabetic rats 201
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome 200
[Cardio-regulatory reflexes in patients with alcoholic liver cirrhosis]. 199
A case report of PTH elevation due to immunoassay interference 199
Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats 196
Meta-analysis on the effect of mild primary hyperparathyroidism and parathyroidectomy upon arterial stiffness 196
Increase in Mas1 Oncogene-Receptor Gene Expression in Colon Cancer 195
[Distensibility of large arteries after chronic treatment with nicardipine SR in aged hypertensive patients]. 194
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. 193
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 191
Inhibition of angiotensin converting enzyme (ACE) in plasma and tissue 189
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 189
Salt blocks the renal benefits of ramipril in diabetic hypertensive rats 187
Localization of angiotensin converting enzyme in rat heart 187
TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases 187
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. 186
Totale 27.474
Categoria #
all - tutte 110.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.077 0 0 112 263 114 225 132 69 227 233 167 535
2022/20233.468 350 502 346 480 232 588 23 308 362 55 153 69
2023/20242.046 161 133 149 94 212 236 350 300 68 50 149 144
2024/20254.328 92 114 154 386 399 490 349 270 585 595 435 459
2025/202611.273 1.361 578 700 944 1.028 947 1.599 325 1.221 1.499 574 497
2026/20271.714 500 797 417 0 0 0 0 0 0 0 0 0
Totale 39.919